Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome
Open accessAbstract
BACKGROUND: Women with polycystic ovary syndrome (PCOS) have higher risk for cardiovascular disease (CVD). Copeptin has been found to be predictive for myocardial ischemia. We tested whether copeptin is the predictor for CVD in PCOS patients, who have an increased risk of cardiovascular disease. METHODS: This was a cross sectional controlled study conducted in a training and research hospital. The study population consisted of 40 reproductive-age PCOS women and 43 control subjects. We evaluated anthropometric and metabolic parameters, carotid intima media thickness and copeptin levels in both PCOS patients and control group. RESULTS: Mean fasting insulin, homeostasis model assessment insulin resistance index (HOMA-IR), triglyceride, total cholesterol, low density lipoprotein cholesterol (LDL-C), free testosterone, 17-OH progesterone, Dehydroepiandrosterone sulfate (DHEAS), carotid intima media thickness (CIMT) levels were significantly higher in PCOS patients. Mean copeptin level was in 12.61 ± 3.05 pmol/L in PCOS patients while mean copeptin level was 9.60 ± 2.80 pmol/L in healthy control women (p < 0.001). After adjustment for age and BMI, copeptin level was positive correlated with fasting insulin, free testosterone levels, CIMT, and HOM A-IR. CONCLUSIONS: Copeptin appeared to have an important role in metabolic response and subsequent development of atherosclerosis in insulin resistant, hyperandrogenemic PCOS patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previous cross-sectional studies evaluating MR-proADM, MR-proANP and copeptin in PCOS and healthy controls have produced contradicting results.
“The three biomarkers have previously been evaluated in PCOS and healthy controls in cross-sectional studies, with contradicting results (13, 14, 15, 16, 17, 18).”
From Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556 · see citing works
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463 · see citing works
Men at risk: occupation and male infertility.
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219 · see citing works
Isolation and characterization
Turksen, K. (2006) · Humana Press eBooks · Cited by 2,082 · see citing works
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005 · see citing works
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360 · see citing works
Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin
Morgenthaler, N. G., Struck, J., Alonso, C., & Bergmann, A. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.060038 · Cited by 1,166 · see citing works
Lawrence, J., Douglas, P., & Gandy, J. (2016) · doi:10.1002/9781119163411.ch73 · Cited by 1,014 · see citing works
Low grade chronic inflammation in women with polycystic ovarian syndrome
Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640 · see citing works
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466 · see citing works
Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction
Reichlin, T., Hochholzer, W., Stelzig, C., Laule, K., Freidank, H., Morgenthaler, N. G., Bergmann, A., Potocki, M., Noveanu, M., Breidthardt, T., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.076 · Cited by 434 · see citing works
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque‐Ramírez, M., & Millán, J. L. S. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 420 · see citing works
Copeptin: clinical use of a new biomarker
Morgenthaler, N. G., Struck, J., Jochberger, S., & Dünser, M. W. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.11.001 · Cited by 412 · see citing works
Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome
Pasquali, R., Gambineri, A., & Pagotto, U. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.00990.x · Cited by 359 · see citing works
Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.
(2003) · Critical Care · doi:10.1186/cc2337 · Cited by 356 · see citing works
C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial Infarction
Khan, S. Q., Dhillon, O. S., O’Brien, R. J., Struck, J., Quinn, P. A., Morgenthaler, N. G., Squire, I. B., Davies, J. E., Bergmann, A., & Ng, L. L. (2007) · Circulation · doi:10.1161/circulationaha.106.685503 · Cited by 353 · see citing works
Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
Keller, T., Tzikas, S., Zeller, T., Czyz, E., Lillpopp, L., Ojeda, F., Roth, A., Bickel, C., Baldus, S. E., Sinning, C., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.029 · Cited by 334 · see citing works
Plasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299 · cited 2× · see citing works
“001) in a large population of 4742 subjects (cross-sectionally) [30].”
BackgroundMethodOrio, F., Palomba, S., Spinelli, L., Cascella, T., Tauchmanovà, L., Zullo, F., Lombardi, G., & Colao, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032049 · Cited by 275 · see citing works
Altered Vascular Function in Young Women with Polycystic Ovary Syndrome
Kelly, C. J., Speirs, A., Gould, G. W., Petrie, J. R., Lyall, H., & Connell, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8199 · Cited by 257 · see citing works
(2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831 · Cited by 254 · see citing works
Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure
Stoiser, B., Mörtl, D., Hülsmann, M., Berger, R., Struck, J., Morgenthaler, N. G., Bergmann, A., & Pacher, R. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01724.x · Cited by 226 · see citing works
Voors, A. A., von Haehling, S., Anker, S. D., Hillege, H. L., Struck, J., Hartmann, O., Bergmann, A., Squire, I., van Veldhuisen, D. J., Dickstein, K., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp098 · Cited by 222 · see citing works
Enhörning, S., Bankir, L., Bouby, N., Struck, J., Hedblad, B., Persson, M., Morgenthaler, N. G., Nilsson, P. M., & Melander, O. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.88 · Cited by 193 · see citing works
Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome
Enhörning, S., Struck, J., Wirfält, E., Hedblad, B., Morgenthaler, N. G., & Melander, O. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2981 · Cited by 177 · see citing works
Víctor, V. M., Rocha, M., Bañuls, C., Álvarez, Á., de Pablo, C., Sánchez-Serrano, M., Gomez, M., & Hernández‐Mijares, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0651 · Cited by 132 · see citing works
A Glycopeptide from the Posterior Lobe of Pig Pituitaries
HOLWERDA, D. A. (1972) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1972.tb01918.x · Cited by 129 · see citing works
Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions
Whitton, P. D., Rodrigues, L. M., & Hems, D. A. (1978) · Biochemical Journal · doi:10.1042/bj1760893 · Cited by 123 · see citing works
The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis
Keppens, S., & De Wulf, H. (1979) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(79)90371-4 · Cited by 98 · see citing works
Gu, Y. L., Voors, A. A., Zijlstra, F., Hillege, H. L., Struck, J., Masson, S., Vago, T., Anker, S. D., van den Heuvel, A. F. M., van Veldhuisen, D. J., et al. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0343-y · Cited by 83 · see citing works
Abu-Basha, E. A., Yibchok-anun, S., & Hsu, W. H. (2002) · Metabolism · doi:10.1053/meta.2002.34052 · Cited by 80 · see citing works
Cardiovascular risk in women with polycystic ovary syndrome
Giallauria, F., Orio, F., Palomba, S., Lombardi, G., Colao, A., & Vigorito, C. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32830b58d4 · Cited by 75 · see citing works
Orio, F., Palomba, S., Cascella, T., Tauchmanovà, L., Nardo, L. G., Biase, S. D., Labella, D., Russo, T., Tolino, A., Zullo, F., et al. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61634-3 · Cited by 72 · see citing works
High Prevalence of Diabetes in Adana, a Southern Province of Turkey
Gökçel, A., Özşahin, A. K., Sezgin, N., Karakose, H., Ertörer, M. E., Akbaba, M., Baklaci, N., Şengül, A., & Guvener, N. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3031 · Cited by 66 · see citing works
von Haehling, S., Papassotiriou, J., Morgenthaler, N. G., Hartmann, O., Doehner, W., Stellos, K., Wurster, T. H., Schuster, A., Nagel, E. C., Gawaz, M., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.12.105 · Cited by 53 · see citing works
Kılıç, T., Ural, E., Oner, G., Şahı̇n, T., Kiliç, M., Yavuz, Ş., Kanko, M., Kahraman, G., Bildirici, U., Berki, K. T., et al. (2009) · PubMed · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
New markers of insulin resistance in polycystic ovary syndrome
Polak, K., Czyzyk, A., Simoncini, T., & Męczekalski, B. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0523-8 · Cited by 258 · see citing works
Markers of insulin resistance in Polycystic ovary syndrome women: An update
Amisi, C. A. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.129 · Cited by 149 · see citing works
GLUT4 Storage Vesicles: Specialized Organelles for Regulated Trafficking.
Li, D. T., Habtemichael, E. N., Julca-Zevallos, O., Sales, C., Westergaard, X. O., DeVries, S. G., Ruiz, D. M., Sayal, B. S., & Bogan, J. S. (2019) · Europe PMC (PubMed Central) · Cited by 46 · see citing works
Hypertension in Polycystic Ovary Syndrome: Novel Insights
Μacut, D., Mladenović, V., Bjekić-Macut, J., Livadas, S., Stanojlović, O. P., Hrnčić, D., Rašić-Marković, A., Milutinović, D. V., & Andric, Z. G. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190531071422 · Cited by 45 · see citing works
Pinto, J., Cera, N., & Pignatelli, D. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02329-y · Cited by 50 · see citing works
Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
Frøssing, S., Nylander, M., Kistorp, C., Skouby, S. O., & Faber, J. (2018) · Endocrine Connections · doi:10.1530/ec-17-0327 · Cited by 38 · see citing works
Jalleh, R. J., & Torpy, D. J. (2021) · Clinical Biochemist Reviews · doi:10.33176/aacb-20-00001 · Cited by 36 · see citing works
Taskin, M. I., Bulbul, E., Adali, E., Hismiogulları, A. A., & Inceboz, U. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.03.006 · Cited by 36 · see citing works
Copeptin Testing in Acute Myocardial Infarction: Ready for Routine Use?
Reinstadler, S. J., Klug, G., Feistritzer, H., Metzler, B., & Mair, J. M. (2015) · Disease Markers · doi:10.1155/2015/614145 · Cited by 32 · see citing works
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update
Profili, N. I., Castelli, R., Gidaro, A., Manetti, R., Maioli, M., Petrillo, M., Capobianco, G., & Delitala, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030698 · Cited by 24 · see citing works
Deveer, M., Deveer, R., Basaran, O., Turkcu, U. O., Akbaba, E., Cullu, N., Turhan, N., Kucuk, M., & Kasap, B. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2375w · Cited by 22 · see citing works
Vasopressin inactivation: Role of insulin-regulated aminopeptidase
Li, D. T., Habtemichael, E. N., & Bogan, J. S. (2020) · Vitamins and hormones · doi:10.1016/bs.vh.2019.08.017 · Cited by 22 · see citing works
The cardiovascular aspects of a Ménière's disease population – A pilot study
Rego, Â. R., Dias, D., Pinto, A. N., Castro, S. S. E., Feliciano, T., & Sousa, C. A. E. (2019) · Journal of Otology · doi:10.1016/j.joto.2019.01.004 · Cited by 21 · see citing works
Sun, D., Wu, Y., Ding, M., & Zhu, F. (2022) · Angiology · doi:10.1177/00033197211072598 · Cited by 20 · see citing works
Copeptin as a novel biomarker of cardiometabolic syndrome
Szmygin, H., Szydełko, J., & Matyjaszek-Matuszek, B. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0072 · Cited by 20 · see citing works
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.37 · Cited by 19 · see citing works
Yin, C., Liu, W., Xu, E., Zhang, M., Lv, W., Qi, L., & Xiao, Y. (2020) · Annals of Nutrition and Metabolism · doi:10.1159/000508883 · Cited by 18 · see citing works
A Copeptin as a Predictor Marker for Insulin Resistance Among Women with Polycystic Ovary Syndrome
Ali, A. I., Nori, W., & Alrawi, S. (2021) · Current Women s Health Reviews · doi:10.2174/1573404817666211208152049 · Cited by 15 · see citing works
Dong, S., Li, C., Liang, W., Chen, M., Bi, Y.-T., & Li, X. (2014) · Peptides · doi:10.1016/j.peptides.2014.06.016 · Cited by 13 · see citing works
Is copeptin a new potential biomarker of insulin resistance in polycystic ovary syndrome?
Widecka, J., Ożegowska, K., Banaszewska, B., Kazienko, A., Safranow, K., Branecka-Woźniak, D., Pawelczyk, L. A., & Kurzawa, R. (2019) · Ginekologia Polska · doi:10.5603/gp.2019.0021 · Cited by 13 · see citing works
Kłosowicz, M., Leksa, D., Bartusik‐Aebisher, D., Myśliwiec, A., Dynarowicz, K., & Aebisher, D. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46090564 · Cited by 9 · see citing works
Yamamoto, K., Nakano, Y., Iwata, N., Soejima, Y., Suyama, A., Hasegawa, T., & Otsuka, F. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.058 · Cited by 7 · see citing works
Sarhat, E. R., & Abbas, M. Q. (2018) · Tikrit Journal of Pure Science · doi:10.25130/tjps.v23i4.515 · Cited by 6 · see citing works
Frøssing, S., Nylander, M., Aziz, M., Skouby, S. O., Kistorp, C., & Faber, J. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1202915 · Cited by 3 · see citing works
Apelin-36 and Copeptin Levels in Polycystic Ovary Syndrome
Saedii, A. A. F., Kamal, A. M., Abdelnaem, E. A., & Matta, R. A. (2017) · Journal of Infectious Diseases and Treatment · doi:10.21767/2472-1093.100030 · Cited by 3 · see citing works
The Vasopressin System in Metabolic Syndrome and Insulin Resistance – a Mini-Review
Vintilă, M., Coculescu, M., Grigorescu, F., & Poiană, C. (2016) · Medicina Moderna - Modern Medicine · Cited by 3 · see citing works
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.37 · Cited by 1 · see citing works
Xiao, Y., Yin, C., Liu, W., Xu, E., Weicheng, L., & Qi, L. (2020) · doi:10.21203/rs.2.23887/v1 · Cited by 1 · see citing works
Non-Hemodynamic Components of EVA
Lambrinoudaki, I. V. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801387-8.00018-1
aly, A., Elfeshawy, M. S., El-Fatah, A. I. A., & Saeed, A. (2020) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.21608/aimj.2020.27820.1197
Polikistik Over Sendromlu Kadınlarda İnsülin Direnci ile Serum Copeptin Düzeyi Arasındaki İlişki
Canbolat, K. H., Gök, K., Tüten, N., Köse, O., Kücür, M., Ekmekçi, Ö. B., Açıkgöz, A. S., Öncül, M., & Tüten, A. (2022) · Sakarya Medical Journal · doi:10.31832/smj.1113885
Nonhemodynamic Components of EVA: Polycystic Ovary Syndrome (PCOS)
Lambrinoudaki, I. V., & Armeni, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00004-0
Yildirim, E. O., & Görkem, Ü. (2024) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2024.65703
Ma, M., Liu, G., Wang, K., Cao, T., Shen, L., Hou, S., Xi, X.-X., & Feng, H. (2025) · Research Square · doi:10.21203/rs.3.rs-7003646/v1
Diagnostic Criteria of PCOS: Future Challenges and Controversies
Dhramalingam, M., & Ganavi, Y. P. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010007
- Authors
- Karbek, B., Ozbek, M., Karakose, M., Topaloglu, O., Bozkurt, N., Cakır, E., Aslan, M., & Delibasi, T.
- Affiliations
- Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi (TR)
- Venue
- Journal of Ovarian Research
- Published
- 2014
- Volume
- 7
- Issue
- 1
- Pages
- 31
- ISSN
- 1757-2215 (ISSN-L)
- PMC
- PMC3995558
- OpenAlex
- W2161207736
- Cited by
- 35
- References
- 38
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 4 · 2014: 1
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Ovarian Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- copeptin, polycystic ovary syndrome, cardiovascular risk, vasopressin, carotid intima-media thickness, atherosclerosis, insulin resistance, hyperandrogenism, free testosterone, cardiovascular biomarkers
- MeSH terms
- Adolescent, Adult, Blood Glucose, Carotid Artery Diseases, Cross-Sectional Studies, Female, Glycopeptides, Hormones, Hospitals, Teaching, Humans, Insulin, Insulin Resistance, Lipids, Polycystic Ovary Syndrome, Predictive Value of Tests, Prognosis, Risk Factors, Turkey, Biomarkers, Case-Control Studies, Hyperandrogenism, Young Adult, Carotid Intima-Media Thickness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
